U USANA HEALTH SCIENCES INC.
| Market Cap | $311.92M |
| P/E Ratio | 29.14 |
| Forward P/E | 6.10 |
| Dividend Yield | — |
| Beta | 0.70 |
| 52W Range | $16.90 - $35.43 |
| # Hedge Funds | 1 |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Richard Pzena Pzena Investment Management | 0.07% | $22.27M | 1,134,429 | Reduce 6.45% |
Insider Trading
| Insider Name of the company insider who made the trade 10 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| FULLER GILBERT A | Sale | 1,058 | $17.00 | $17.99K | 20 Mar 2026 | 20 Mar 2026 |
| Benedict PeterCHIEF INFORMATION OFFICER | Sale | 4,553 | $19.38 | $88.26K | 03 Mar 2026 | 03 Mar 2026 |
| Foukas JoshuaCHIEF LEGAL OFFICER | Sale | 4,461 | $21.35 | $95.22K | 20 Feb 2026 | 23 Feb 2026 |
| Benedict PeterCHIEF INFORMATION OFFICER | Sale | 2,673 | $20.95 | $56.00K | 10 Dec 2025 | 11 Dec 2025 |
| Mulham David MulhamCHIEF SALES OFFICER | Sale | 873 | $21.00 | $18.33K | 10 Dec 2025 | 11 Dec 2025 |
| Winssinger Frederic J | Sale | 2,000 | $19.21 | $38.42K | 10 Nov 2025 | 10 Nov 2025 |
| FULLER GILBERT A | Sale | 1,057 | $21.48 | $22.70K | 03 Nov 2025 | 04 Nov 2025 |
| Gilbert A FullerDirector | Sale | 1,057 | $21.48 | $22.70K | 03 Nov 2025 | 04 Nov 2025 |
| Fleming John Turman | Sale | 1,750 | $19.79 | $34.63K | 31 Oct 2025 | 03 Nov 2025 |
| John Turman FlemingDirector | Sale | 1,750 | $19.79 | $34.63K | 31 Oct 2025 | 03 Nov 2025 |
Frequently Asked Questions
What is USNA stock price today?
USANA HEALTH SCIENCES INC. (USNA) is currently trading at $16.90. The stock has a 52-week range of $16.90 to $35.43 and a market capitalization of $311.92M.
Is USNA a good stock to buy in 2026?
USANA HEALTH SCIENCES INC. has a P/E ratio of 29.1 (forward P/E: 6.1), a dividend yield of none, and 1-year performance of -33.6%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling USNA stock?
There have been 10 insider transactions for USNA in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has USNA stock performed over the past year?
USANA HEALTH SCIENCES INC. (USNA) has returned -33.6% over the past 12 months. The stock traded between $16.90 and $35.43 during this period, and is currently at $16.90.
Which hedge funds own USNA (USANA HEALTH SCIENCES INC.)?
1 tracked hedge funds currently hold USNA in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is USNA's market cap and valuation?
USANA HEALTH SCIENCES INC. (USNA) has a market capitalization of $311.92M. The trailing P/E ratio is 29.1 and forward P/E is 6.1. The stock is classified in the Consumer Defensive sector.
What is USNA's revenue and profitability?
USANA HEALTH SCIENCES INC. reported revenue of $925.26M with net income of $10.76M and a profit margin of 0.01%. The stock has a beta of 0.70.
What sector is USNA in and who are its biggest institutional holders?
USANA HEALTH SCIENCES INC. (USNA) operates in the Consumer Defensive sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.